167 related articles for article (PubMed ID: 38271373)
41. Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia.
Di Sebastiano KM; Yang L; Zbuk K; Wong RK; Chow T; Koff D; Moran GR; Mourtzakis M
Br J Nutr; 2013 Jan; 109(2):302-12. PubMed ID: 23021109
[TBL] [Abstract][Full Text] [Related]
42. Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients.
Anandavadivelan P; Brismar TB; Nilsson M; Johar AM; Martin L
Clin Nutr; 2016 Jun; 35(3):724-30. PubMed ID: 26065721
[TBL] [Abstract][Full Text] [Related]
43. Ovarian cancer ascites induces skeletal muscle wasting in vitro and reflects sarcopenia in patients.
Ubachs J; van de Worp WRPH; Vaes RDW; Pasmans K; Langen RC; Meex RCR; van Bijnen AAJHM; Lambrechts S; Van Gorp T; Kruitwagen RFPM; Olde Damink SWM; Rensen SS
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):311-324. PubMed ID: 34951138
[TBL] [Abstract][Full Text] [Related]
44. Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study.
Järvinen T; Ilonen I; Kauppi J; Salo J; Räsänen J
World J Surg Oncol; 2018 Feb; 16(1):27. PubMed ID: 29433514
[TBL] [Abstract][Full Text] [Related]
45. [Sarcopenia in patients with pancreatic cancer, an independant prognostic factor].
Mandl J; Baumer S; Holtzem B; Theurer R; Zorger N; Pech O
Z Gastroenterol; 2023 Oct; 61(10):1365-1370. PubMed ID: 36482058
[TBL] [Abstract][Full Text] [Related]
46. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
Biolo G; Cederholm T; Muscaritoli M
Clin Nutr; 2014 Oct; 33(5):737-48. PubMed ID: 24785098
[TBL] [Abstract][Full Text] [Related]
47. Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection.
Yabusaki N; Fujii T; Yamada S; Suzuki K; Sugimoto H; Kanda M; Nakayama G; Koike M; Fujiwara M; Kodera Y
Int J Surg; 2016 Jun; 30():136-42. PubMed ID: 27154615
[TBL] [Abstract][Full Text] [Related]
48. Computed tomography diagnosed cachexia and sarcopenia in 725 oncology patients: is nutritional screening capturing hidden malnutrition?
Ní Bhuachalla ÉB; Daly LE; Power DG; Cushen SJ; MacEneaney P; Ryan AM
J Cachexia Sarcopenia Muscle; 2018 Apr; 9(2):295-305. PubMed ID: 29271097
[TBL] [Abstract][Full Text] [Related]
49. The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma.
Nishikawa D; Hanai N; Suzuki H; Koide Y; Beppu S; Hasegawa Y
ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):1-9. PubMed ID: 29393251
[TBL] [Abstract][Full Text] [Related]
50. SARC-F as a screening tool to detect computed tomography-based sarcopenia and myosteatosis among older adults with cancer.
Hess DL; Harmon C; Bhatia S; Williams GR; Giri S
Cancer Med; 2023 Nov; 12(22):20690-20698. PubMed ID: 37916460
[TBL] [Abstract][Full Text] [Related]
51. Feasibility of using chest computed tomography (CT) imaging at the first lumbar vertebra (L1) level to assess skeletal muscle mass: a retrospective study.
Liu S; Han X; Li J; Xie X; Yang Y; Jiang W; Liu L; Liu Z
PeerJ; 2023; 11():e16652. PubMed ID: 38099314
[TBL] [Abstract][Full Text] [Related]
52. A window beneath the skin: how computed tomography assessment of body composition can assist in the identification of hidden wasting conditions in oncology that profoundly impact outcomes.
Daly LE; Prado CM; Ryan AM
Proc Nutr Soc; 2018 May; 77(2):135-151. PubMed ID: 29745361
[TBL] [Abstract][Full Text] [Related]
53. Nutritional and immune impairments and their effects on outcomes in early pancreatic cancer patients undergoing pancreatoduodenectomy.
Tumas J; Tumiene B; Jurkeviciene J; Jasiunas E; Sileikis A
Clin Nutr; 2020 Nov; 39(11):3385-3394. PubMed ID: 32184025
[TBL] [Abstract][Full Text] [Related]
54. Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer.
Griffin OM; Duggan SN; Ryan R; McDermott R; Geoghegan J; Conlon KC
Pancreatology; 2019 Sep; 19(6):850-857. PubMed ID: 31362865
[TBL] [Abstract][Full Text] [Related]
55. Low muscle mass determined by psoas muscle area does not correlate with dual-energy x-ray absorptiometry or total lumbar muscle mass scores: A prospective cohort study of patients undergoing vascular surgery.
Thurston BE; Thomas JM; Miller M; Delaney CL
Vascular; 2023 Feb; 31(1):107-114. PubMed ID: 35104187
[No Abstract] [Full Text] [Related]
56. Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial.
Kurk SA; Peeters PHM; Dorresteijn B; de Jong PA; Jourdan M; Creemers GM; Erdkamp FLG; de Jongh FE; Kint PAM; Poppema BJ; Radema SA; Simkens LHJ; Tanis BC; Tjin-A-Ton MLR; Van Der Velden A; Punt CJA; Koopman M; May AM
Cancer Med; 2020 Feb; 9(3):1033-1043. PubMed ID: 31850687
[TBL] [Abstract][Full Text] [Related]
57. Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy.
Shachar SS; Deal AM; Weinberg M; Nyrop KA; Williams GR; Nishijima TF; Benbow JM; Muss HB
Clin Cancer Res; 2017 Feb; 23(3):658-665. PubMed ID: 27489287
[TBL] [Abstract][Full Text] [Related]
58. The Effect of Sarcopenia and Metabolic PET-CT Parameters on Survival in Locally Advanced Non-Small Cell Lung Carcinoma.
Karaman E; Hursoy N; Goksel S
Nutr Cancer; 2023; 75(1):286-295. PubMed ID: 35959787
[TBL] [Abstract][Full Text] [Related]
59. Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin.
Zhong X; Narasimhan A; Silverman LM; Young AR; Shahda S; Liu S; Wan J; Liu Y; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2146-2161. PubMed ID: 35510530
[TBL] [Abstract][Full Text] [Related]
60. Prognostic significance of nutritional markers in metastatic gastric and esophageal adenocarcinoma.
Ma LX; Taylor K; Espin-Garcia O; Anconina R; Suzuki C; Allen MJ; Honorio M; Bach Y; Allison F; Chen EX; Brar S; Swallow CJ; Yeung J; Darling GE; Wong R; Kalimuthu SN; Jang RW; Veit-Haibach P; Elimova E
Cancer Med; 2021 Jan; 10(1):199-207. PubMed ID: 33295697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
